The Experts below are selected from a list of 1299 Experts worldwide ranked by ideXlab platform

Akihiro Hosono - One of the best experts on this subject based on the ideXlab platform.

  • no association between hpv vaccine and reported post vaccination symptoms in japanese young women results of the nagoya study
    Papillomavirus Research, 2018
    Co-Authors: Sadao Suzuki, Akihiro Hosono
    Abstract:

    Nagoya City introduced free HPV vaccination in 2010 and in April 2013 the Ministry of Health, Labour and Welfare included the HPV vaccine in the National Immunization Program. However, in June 2013, the Ministry suspended proactive recommendation of the vaccine after unconfirmed reports of adverse events. To investigate any potential association between the vaccine and reported symptoms, Nagoya City conducted a questionnaire-based survey. Participants were 71,177 female residents of Nagoya City born between April 2, 1994 and April 1, 2001. The anonymous postal questionnaire investigated the onset of 24 symptoms (primary outcome), associated hospital visits, frequency, and influence on school attendance. Totally, 29,846 residents responded. No significant increase in occurrence of any of the 24 reported post-HPV vaccination symptoms was found. The vaccine was associated with increased age-adjusted odds of hospital visits for "abnormal amount of menstrual bleeding" (OR: 1.43, 95% CI: 1.13-1.82), "Irregular Menstruation" (OR: 1.29, 95% CI: 1.12-1.49), "severe headaches" (OR: 1.19, 95% CI: 1.02-1.39), and chronic, persisting "abnormal amount of menstrual bleeding" (OR 1.41, 95% CI: 1.11-1.79). No symptoms significantly influenced school attendance and no accumulation of symptoms was observed. The results suggest no causal association between the HPV vaccines and reported symptoms.

  • No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study
    Elsevier, 2018
    Co-Authors: Sadao Suzuki, Akihiro Hosono
    Abstract:

    Nagoya City introduced free HPV vaccination in 2010 and in April 2013 the Ministry of Health, Labour and Welfare included the HPV vaccine in the National Immunization Program. However, in June 2013, the Ministry suspended proactive recommendation of the vaccine after unconfirmed reports of adverse events. To investigate any potential association between the vaccine and reported symptoms, Nagoya City conducted a questionnaire-based survey.Participants were 71,177 female residents of Nagoya City born between April 2, 1994 and April 1, 2001. The anonymous postal questionnaire investigated the onset of 24 symptoms (primary outcome), associated hospital visits, frequency, and influence on school attendance.Totally, 29,846 residents responded. No significant increase in occurrence of any of the 24 reported post-HPV vaccination symptoms was found. The vaccine was associated with increased age-adjusted odds of hospital visits for “abnormal amount of menstrual bleeding” (OR: 1.43, 95% CI: 1.13–1.82), “Irregular Menstruation” (OR: 1.29, 95% CI: 1.12–1.49), “severe headaches” (OR: 1.19, 95% CI: 1.02–1.39), and chronic, persisting “abnormal amount of menstrual bleeding” (OR 1.41, 95% CI: 1.11–1.79). No symptoms significantly influenced school attendance and no accumulation of symptoms was observed.The results suggest no causal association between the HPV vaccines and reported symptoms. Keywords: Human papilloma virus vaccine, Post-vaccination symptom, Population based epidemiological study, Questionnair

Sadao Suzuki - One of the best experts on this subject based on the ideXlab platform.

  • no association between hpv vaccine and reported post vaccination symptoms in japanese young women results of the nagoya study
    Papillomavirus Research, 2018
    Co-Authors: Sadao Suzuki, Akihiro Hosono
    Abstract:

    Nagoya City introduced free HPV vaccination in 2010 and in April 2013 the Ministry of Health, Labour and Welfare included the HPV vaccine in the National Immunization Program. However, in June 2013, the Ministry suspended proactive recommendation of the vaccine after unconfirmed reports of adverse events. To investigate any potential association between the vaccine and reported symptoms, Nagoya City conducted a questionnaire-based survey. Participants were 71,177 female residents of Nagoya City born between April 2, 1994 and April 1, 2001. The anonymous postal questionnaire investigated the onset of 24 symptoms (primary outcome), associated hospital visits, frequency, and influence on school attendance. Totally, 29,846 residents responded. No significant increase in occurrence of any of the 24 reported post-HPV vaccination symptoms was found. The vaccine was associated with increased age-adjusted odds of hospital visits for "abnormal amount of menstrual bleeding" (OR: 1.43, 95% CI: 1.13-1.82), "Irregular Menstruation" (OR: 1.29, 95% CI: 1.12-1.49), "severe headaches" (OR: 1.19, 95% CI: 1.02-1.39), and chronic, persisting "abnormal amount of menstrual bleeding" (OR 1.41, 95% CI: 1.11-1.79). No symptoms significantly influenced school attendance and no accumulation of symptoms was observed. The results suggest no causal association between the HPV vaccines and reported symptoms.

  • No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study
    Elsevier, 2018
    Co-Authors: Sadao Suzuki, Akihiro Hosono
    Abstract:

    Nagoya City introduced free HPV vaccination in 2010 and in April 2013 the Ministry of Health, Labour and Welfare included the HPV vaccine in the National Immunization Program. However, in June 2013, the Ministry suspended proactive recommendation of the vaccine after unconfirmed reports of adverse events. To investigate any potential association between the vaccine and reported symptoms, Nagoya City conducted a questionnaire-based survey.Participants were 71,177 female residents of Nagoya City born between April 2, 1994 and April 1, 2001. The anonymous postal questionnaire investigated the onset of 24 symptoms (primary outcome), associated hospital visits, frequency, and influence on school attendance.Totally, 29,846 residents responded. No significant increase in occurrence of any of the 24 reported post-HPV vaccination symptoms was found. The vaccine was associated with increased age-adjusted odds of hospital visits for “abnormal amount of menstrual bleeding” (OR: 1.43, 95% CI: 1.13–1.82), “Irregular Menstruation” (OR: 1.29, 95% CI: 1.12–1.49), “severe headaches” (OR: 1.19, 95% CI: 1.02–1.39), and chronic, persisting “abnormal amount of menstrual bleeding” (OR 1.41, 95% CI: 1.11–1.79). No symptoms significantly influenced school attendance and no accumulation of symptoms was observed.The results suggest no causal association between the HPV vaccines and reported symptoms. Keywords: Human papilloma virus vaccine, Post-vaccination symptom, Population based epidemiological study, Questionnair

Kyoung Ah Baek - One of the best experts on this subject based on the ideXlab platform.

Rita, Rauza Sukma - One of the best experts on this subject based on the ideXlab platform.

  • Perbandingan Kadar Low Density Lipoprotein dan High Density Lipoprotein Antara Akseptor KB Pil Kombinasi Dengan Depo Medroksiprogesteron Asetat
    'Universitas Batanghari Jambi', 2019
    Co-Authors: Sitinjak, Helti Lestari, Rita, Rauza Sukma, Yusrawati Yusrawati
    Abstract:

    More than six million women worldwide use contraceptive injection and the popular contraceptive method used is contraceptive pill. Combined pill contraceptives have side effects, which are increased triglyceride and total cholesterol levels and changes in carbohydrate metabolism while the DMPA is Irregular Menstruation/amenorrhea, weight changes and lipid changes.This research is an observational with Cross Sectional Comparative approach to 36 combination pill acceptor and 36 DMPA acceptor. This study was conducted ini the area of Andalas and Lubuk Buaya Health Center. The sampling method used in this research was simple random sampling method. The analysis was used T-Independent test. The results showed that Low Density Lipoprotein levels DMPA (63,97 ± 12,75 mg/dl) vs combined contraceptive pill (89,66 ± 28,39 mg/dl) p = 0,25 and High Density Lipoprotein levels DMPA (63,97± 12,75 mg/dl) vs combined contraceptive pill (60,06 ± 15,57 mg/dl), p = 0,25. Results of this study concluded that there was significant difference in average of Low Density Lipoprotein and High Density Lipoprotein levels in the combined contraceptive pill and Medroxy Progesteron Acetate Depot acceptor but statistically the difference was no significant

  • Perbandingan Kadar High Density Lipoprotein dan Indeks Massa Tubuh antara Akseptor KB Pil Kombinasi dengan Depo Medroksiprogesteron
    Faculty Of Public Health Hasanuddin University Makassar, 2019
    Co-Authors: Sitinjak, Helti Lestari, Rita, Rauza Sukma
    Abstract:

    More than six million women worldwide use contraceptive injection and the popular contraceptive methodused is contraceptive pill. This is due to one of the side effects of combination pill contraception is to increasetriglyceride levels, total cholesterol and changes in carbohydrate metabolism while the side effects of DepotMedroxyprogesterone Acetate are Irregular Menstruation/amenorrhea, changes in body weight and lipid changes.This research is an observational with cross sectional comparative approach to 36 combination pill acceptorand 36 Depot Medroxyprogesterone Acetate acceptor. This study was conducted ini the area of Andalas andLubuk Buaya Health Center. The sampling method used in this research was simple random sampling method.The analysis was used T-Independent test and chi square test. The results showed that High Density Lipoproteinleves Depot Medroxyprogesterone Acetate (63,97±12,75 mg/dl) vs combined contraceptive pill (60,06±15,57 mg/dl), p=0,25 and Body Mass Index levels of overweight combined contraceptive pill acceptor higher than DepotMedroxyprogesterone Acetate (p=0,08). Results of this study concluded was that there were no significantdifferences in the levels of High Density Lipoprotein and Body Mass Index between combined contraceptive pilland Depot Medroxyprogesterone Acetate accepto

Sitinjak, Helti Lestari - One of the best experts on this subject based on the ideXlab platform.

  • Perbandingan Kadar Low Density Lipoprotein dan High Density Lipoprotein Antara Akseptor KB Pil Kombinasi Dengan Depo Medroksiprogesteron Asetat
    'Universitas Batanghari Jambi', 2019
    Co-Authors: Sitinjak, Helti Lestari, Rita, Rauza Sukma, Yusrawati Yusrawati
    Abstract:

    More than six million women worldwide use contraceptive injection and the popular contraceptive method used is contraceptive pill. Combined pill contraceptives have side effects, which are increased triglyceride and total cholesterol levels and changes in carbohydrate metabolism while the DMPA is Irregular Menstruation/amenorrhea, weight changes and lipid changes.This research is an observational with Cross Sectional Comparative approach to 36 combination pill acceptor and 36 DMPA acceptor. This study was conducted ini the area of Andalas and Lubuk Buaya Health Center. The sampling method used in this research was simple random sampling method. The analysis was used T-Independent test. The results showed that Low Density Lipoprotein levels DMPA (63,97 ± 12,75 mg/dl) vs combined contraceptive pill (89,66 ± 28,39 mg/dl) p = 0,25 and High Density Lipoprotein levels DMPA (63,97± 12,75 mg/dl) vs combined contraceptive pill (60,06 ± 15,57 mg/dl), p = 0,25. Results of this study concluded that there was significant difference in average of Low Density Lipoprotein and High Density Lipoprotein levels in the combined contraceptive pill and Medroxy Progesteron Acetate Depot acceptor but statistically the difference was no significant

  • Perbandingan Kadar High Density Lipoprotein dan Indeks Massa Tubuh antara Akseptor KB Pil Kombinasi dengan Depo Medroksiprogesteron
    Faculty Of Public Health Hasanuddin University Makassar, 2019
    Co-Authors: Sitinjak, Helti Lestari, Rita, Rauza Sukma
    Abstract:

    More than six million women worldwide use contraceptive injection and the popular contraceptive methodused is contraceptive pill. This is due to one of the side effects of combination pill contraception is to increasetriglyceride levels, total cholesterol and changes in carbohydrate metabolism while the side effects of DepotMedroxyprogesterone Acetate are Irregular Menstruation/amenorrhea, changes in body weight and lipid changes.This research is an observational with cross sectional comparative approach to 36 combination pill acceptorand 36 Depot Medroxyprogesterone Acetate acceptor. This study was conducted ini the area of Andalas andLubuk Buaya Health Center. The sampling method used in this research was simple random sampling method.The analysis was used T-Independent test and chi square test. The results showed that High Density Lipoproteinleves Depot Medroxyprogesterone Acetate (63,97±12,75 mg/dl) vs combined contraceptive pill (60,06±15,57 mg/dl), p=0,25 and Body Mass Index levels of overweight combined contraceptive pill acceptor higher than DepotMedroxyprogesterone Acetate (p=0,08). Results of this study concluded was that there were no significantdifferences in the levels of High Density Lipoprotein and Body Mass Index between combined contraceptive pilland Depot Medroxyprogesterone Acetate accepto